Anti-tubulin drugs conjugated to anti-ErbB antibodies selectively radiosensitize-Reference-Cited by-同舟云学术

Anti-tubulin drugs conjugated to anti-ErbB antibodies selectively radiosensitize

Published:2016-10-04 Issue:1 Volume:7 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Adams Stephen R.,Yang Howard C.,Savariar Elamprakash N.,Aguilera Joe,Crisp Jessica L.,Jones Karra A.^ORCID,Whitney Michael A.,Lippman Scott M.,Cohen Ezra E. W.,Tsien Roger Y.,Advani Sunil J.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms13019.pdf

Reference48 articles.

1. Marur, S. & Forastiere, A. A. Challenges of integrating chemotherapy and targeted therapy with radiation in locally advanced head and neck squamous cell cancer. Curr. Opin. Oncol. 222, 206–211 (2010).

2. Laine, A. M., Westover, K. D. & Choy, H. Radiation therapy as a backbone of treatment of locally advanced non-small cell lung cancer. Semin. Oncol. 41, 57–68 (2014).

3. Cohen, D. J. & Leichman, L. Controversies in the treatment of local and locally advanced gastric and esophageal cancers. J. Clin. Oncol. 33, 1754–1759 (2015).

4. Herskovic, A. et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N. Engl. J. Med. 326, 1593–1598 (1992).

5. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet 348, 1049–1054 (1996).

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic approach to combating triple-negative breast cancer: ddr1-targeted antibody-drug conjugate combined with pembrolizumab;Journal of Pharmaceutical Analysis;2024-09

2. Long-Term Success With a TDM-1 Biosimilar in Recurrent HER2-Positive Breast Cancer With Multisite Metastases: A Comprehensive Case Study;Cureus;2024-08-16

3. Development of peptides for targeting cell ablation agents concurrently to the Sertoli and Leydig cell populations of the testes: An approach to non-surgical sterilization;PLOS ONE;2024-04-04

4. Radiation therapy, tissue radiosensitization, and potential synergism in the era of novel antibody-drug conjugates;Critical Reviews in Oncology/Hematology;2024-03

5. Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice;Experimental Hematology & Oncology;2024-03-01